In 2019, Evotec acquired Just Biotherapeutics, an AI/ML antibody discovery ... AI-small molecule discovery spaces Compared to the small molecule AI drug discovery ecosystem, this space is evolving ...

designed Lily’s COVID antibody using AI, along with a large library of mouse models. But it wouldn’t be considered “pure play” AI.) Nonetheless, the first pure play AI drug discovery ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Absci's advanced de novo antibody design models will benefit from AMD's optimized AI solutions, potentially leading to reduced infrastructure costs and faster innovation cycles in drug discovery.

By leveraging its proprietary AI ... antibody mimics for therapeutic applications "Our interdisciplinary team is uniquely equipped to tackle the most complex challenges in drug discovery," said ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug ... critical AI drug discovery workloads, including Absci's advanced de novo antibody design ...

With the advent of artificial intelligence (AI), the industry witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, and treatment ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its proprietary AI-driven platform, its partnership with ...